8 Results
June / July 2006
- Screening Strategy for Lead Optimization
Litao Zhang, Ph.D. and Martyn Banks, Ph.D.
Bristol-Myers Squibb - Optimizing Process and Information Flow
Gary K. Mallow, Ph.D., Thomas L. Fare, Ph.D., Ansuman Bagchi, Ph.D., Michael Bevil
Merck Research Laboratories
Merck & Co., Inc. - Ultra-High Performance Liquid Chromatography: Hope or Hype?
Joseph Kofman, Ph.D., Yining Zhao, Ph.D., Todd Maloney, Ph.D., Todd Baumgartner, Robert Buljaski, Ph.D.
Pfizer Global Research and Development - A Risk-Based Approach to Bioanalytical Methods Validations and Sample Analyses During Drug Discovery and Development
Ajai K. Chaudhary, Ph.D., Enaksha, R. Wickremsinhe, Ph.D., Michael J. Berna, and Bradley L. Ackermann, Ph.D.
Eli Lilly and Company - Applications of Cell-Based Imaging Technologies in Toxicity Screening in Drug Discovery and Development
Jinghai J. Xu, Ph.D., Margaret C. Dunn, Arthur R. Smith
Pfizer Global Research and Development - Laboratory Automation for Compound Optimization and Early Development Drug Metabolism: A Wyeth Case Study
Thomas L. Lloyd, Hamza Kandoussi, Joseph A. Short, and Rasmy Talaat, Ph.D.
Wyeth Research - Enabling Technologies in Reducing Drug Attrition Due to Safety Failures
Bruce D. Car, Ph.D.
Bristol-Myers Squibb Co. - Beyond Signal - Transduction: The Role of Phospho-Proteomics in Drug Discovery and Development
Ze'ev Gechtman, Ph.D.
Johnson & Johnson